Avenir Wellness Solutions, Inc. Stock

Equities

AVRW

US23127P1049

Software

Market Closed - OTC Markets 02:05:05 2024-04-26 pm EDT 5-day change 1st Jan Change
0.045 USD -10.00% Intraday chart for Avenir Wellness Solutions, Inc. +5.88% -39.52%
Sales 2021 6.56M Sales 2022 4.9M Capitalization 12.15M
Net income 2021 -13M Net income 2022 -25M EV / Sales 2021 6.26 x
Net Debt 2021 15.62M Net Debt 2022 7.12M EV / Sales 2022 3.94 x
P/E ratio 2021
-1.37 x
P/E ratio 2022
-0.43 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 67.01%
More Fundamentals * Assessed data
Dynamic Chart
Avenir Wellness Solutions, Inc. and Nancy Duitch Enters into Certain Senior Secured Promissory Note and Security Agreement CI
Avenir Wellness Solutions, Inc. announced that it expects to receive $0.25 million in funding CI
Avenir Wellness Solutions, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Avenir Wellness Solutions, Inc. Provides Sales Guidance for the Second Half of 2023 CI
Avenir Wellness Solutions, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Avenir Wellness Solutions, Inc. will Change its Ticker to AVRW from CURR CI
Avenir Wellness Solutions, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Avenir Wellness Solutions, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Avenir Wellness Solutions to Launch Wall Street-Focused Informational Series with Producer New to the Street CI
CURE Pharmaceutical Holding Corp. has Changed its Name to Avenir Wellness Solutions, Inc CI
CURE Pharmaceutical Holding Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
CURE Pharmaceutical Holding Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
CURE Pharmaceutical Holding Corp. Announces Board and Committee Appointments CI
CURE Pharmaceutical Holding Corp. Appoints Gerald Bagg to Its Board of Directors CI
CURE Pharmaceutical Holding Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
More news
1 day-10.00%
1 week+5.88%
Current month+48.03%
1 month+48.03%
3 months-30.66%
6 months-25.00%
Current year-39.52%
More quotes
1 week
0.03
Extreme 0.0325
0.06
1 month
0.03
Extreme 0.0303
0.06
Current year
0.02
Extreme 0.0226
0.08
1 year
0.02
Extreme 0.0226
0.25
3 years
0.02
Extreme 0.0226
1.00
5 years
0.02
Extreme 0.0226
5.83
10 years
0.02
Extreme 0.0226
15.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 69 -
Founder 57 14-05-14
Director of Finance/CFO 62 22-07-21
Members of the board TitleAgeSince
Director/Board Member 65 22-08-15
Founder 57 14-05-14
Chief Executive Officer 69 -
More insiders
Date Price Change Volume
24-04-26 0.045 -10.00% 413
24-04-25 0.05 +53.85% 32,065
24-04-24 0.0325 -20.73% 17,100
24-04-23 0.041 0.00% 3,600
24-04-22 0.041 -3.42% 165,870

Delayed Quote OTC Markets, April 26, 2024 at 02:05 pm EDT

More quotes
Avenir Wellness Solutions, Inc. is a platform technology company. The Company develops proprietary wellness, nutraceutical, and topical delivery systems. The Company is focused on the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve wellness. Its wholly owned subsidiary, The Sera Labs, Inc. (Sera Labs), is engaged the development, production and sale of the Company’s wellness and beauty products. Sera Labs creates products that use science-backed, proprietary oral and topical formulations. The Company sells over 25 products under the brand names Seratopical, Seratopical Revolution SeraLabs, and Nutri-Stri. Sera Labs products are sold direct-to-consumer via online Website orders, including opt-in subscribe and save option, and also online and in-store at national drug, mass retailers, grocery chains and convenience stores and on Amazon.com.
More about the company